Clinical trial
Effectiveness Study of Hylan G-F 20 to Preserve Cartilage in Osteoarthritis of…
NCT00393393 · Cabrini Medical Centre, Other · Unknown status
Key facts
| NCT number | NCT00393393 |
|---|---|
| Title | Effectiveness Study of Hylan G-F 20 to Preserve Cartilage in Osteoarthritis of the Knee |
| Official title | A Single-Blind Prospective Parallel Control Group Pilot Study to Assess the Effect of Hylan G-F 20 (Synvisc) Supplementation on Cartilage Preservation in Osteoarthritis of the Knee |
| Lead sponsor | Cabrini Medical Centre, Other |
| Collaborators | Genzyme, a Sanofi Company Industry |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Osteoarthritis |
| Intervention type | Drug |
| Interventions | intra-articular injection of Hylan G-F 20 |
| Enrollment | 80 |
| Start date | Jan 1, 2006 |
| Completion | Jan 1, 2006 |
| First posted | Oct 27, 2006 |
| Last update posted | Oct 27, 2006 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: